Voyager Therapeutics Inc (VYGR)
Operating Cash Flow Growth
22.31%
Quarterly · Period ending:
VYGR Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported22.31%period ending
Latest reported22.31%period ending
VYGR Quarterly Cash from Operations YoY % (2648.86% → 22.31%)
Year-over-year change
High-resolution chart · PNG
VYGR operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 22.3054% | |
| 11.8116% | |
| -108.2938% | |
| -11.0126% | |
| -5.323% | |
| -164.4835% | |
| 38.851% | |
| -32.8583% | |
| -3,682.0359% | |
| -52.4404% | |
| -94.0542% | |
| -29.8963% | |
| 95.4828% | |
| 258.9293% | |
| -209.3703% | |
| 21.7442% | |
| 18.6292% | |
| 261.67% | |
| 150.9396% | |
| 16.2935% | |
| -7.1506% | |
| 26.0574% | |
| 5.9204% | |
| -14.6485% | |
| 32.8168% | |
| -123.0086% | |
| 4.0578% | |
| -22.2814% | |
| -40.2409% | |
| 157.482% | |
| -64.1364% | |
| -11.0782% | |
| -37.7533% | |
| 440.0728% | |
| -13.3058% | |
| -55.9231% | |
| -68.1594% | |
| -50.6693% | |
| -36.9886% | |
| -50.9481% | |
| -39.1292% | |
| -114.6885% | |
| -99.4366% | |
| -189.824% | |
| -208.5285% | |
| 2,648.8556% |